Skip to main content
PMC home page
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1997 Aug 1;157(3):255–262.

Needle exchange programs: an economic evaluation of a local experience

M Gold 1, A Gafni 1, P Nelligan 1, P Millson 1
PMCID: PMC1227824  PMID: 9269195

Abstract

OBJECTIVE: To determine whether providing a needle exchange program to prevent HIV transmission among injection drug users would cost less than the health care consequences of not having such a program. DESIGN: Incidence outcome model to estimate the number of cases of HIV infection that this program would prevent over 5 years, assuming that the HIV incidence rate would be 2% with the program and 4% without it, and that an estimated 275 injection drug users would use the service over this time. SETTING: Hamilton, Ont. OUTCOME MEASURES: Estimated number of cases of HIV infection expected to be prevented with and without the program over 5 years; estimated lifetime health care costs of treating an AIDS patient. The indirect costs of AIDS to society (e.g., lost productivity and informal caregiving) were not included. Projected costs were adjusted (discounted) to reflect their present value. In a sensitivity analysis, 3 parameters were varied: the estimate of the HIV transmission rate if no needle exchange program were provided, the number of injection drug users participating in the program, and the discount rate. RESULTS: With very conservative estimates, it was predicted that the Hamilton needle exchange program will prevent 24 cases of HIV infection over 5 years, thereby providing cost savings of $1.3 million after the program costs are taken into account. This translates into a ratio of cost savings to costs of 4:1. The sensitivity analysis confirmed that these findings are robust. CONCLUSION: Needle exchange programs are an efficient use of financial resources.

Full Text

The Full Text of this article is available as a PDF (151.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alcabes P., Muñoz A., Vlahov D., Friedland G. Maturity of human immunodeficiency virus infection and incubation period of acquired immunodeficiency syndrome in injecting drug users. Ann Epidemiol. 1994 Jan;4(1):17–26. doi: 10.1016/1047-2797(94)90038-8. [DOI] [PubMed] [Google Scholar]
  2. Brettle R. P. HIV and harm reduction for injection drug users. AIDS. 1991 Feb;5(2):125–136. doi: 10.1097/00002030-199102000-00001. [DOI] [PubMed] [Google Scholar]
  3. Des Jarlais D. C., Friedman S. R., Choopanya K., Vanichseni S., Ward T. P. International epidemiology of HIV and AIDS among injecting drug users. AIDS. 1992 Oct;6(10):1053–1068. doi: 10.1097/00002030-199210000-00001. [DOI] [PubMed] [Google Scholar]
  4. Des Jarlais D. C., Friedman S. R., Stoneburner R. L. HIV infection and intravenous drug use: critical issues in transmission dynamics, infection outcomes, and prevention. Rev Infect Dis. 1988 Jan-Feb;10(1):151–158. doi: 10.1093/clinids/10.1.151. [DOI] [PubMed] [Google Scholar]
  5. Des Jarlais D. C., Hagan H., Friedman S. R., Friedmann P., Goldberg D., Frischer M., Green S., Tunving K., Ljungberg B., Wodak A. Maintaining low HIV seroprevalence in populations of injecting drug users. JAMA. 1995 Oct 18;274(15):1226–1231. doi: 10.1001/jama.274.15.1226. [DOI] [PubMed] [Google Scholar]
  6. Elnitsky S. L., Abernathy T. J. Calgary's needle exchange program: profile of injection drug users. Can J Public Health. 1993 May-Jun;84(3):177–180. [PubMed] [Google Scholar]
  7. Hanvelt R. A., Ruedy N. S., Hogg R. S., Strathdee S., Montaner J. S., O'Shaughnessy M. V., Schechter M. T. Indirect costs of HIV/AIDS mortality in Canada. AIDS. 1994 Oct;8(10):F7–11. doi: 10.1097/00002030-199410000-00001. [DOI] [PubMed] [Google Scholar]
  8. Hellinger F. J. The lifetime cost of treating a person with HIV. JAMA. 1993 Jul 28;270(4):474–478. [PubMed] [Google Scholar]
  9. Holmberg S. D. The estimated prevalence and incidence of HIV in 96 large US metropolitan areas. Am J Public Health. 1996 May;86(5):642–654. doi: 10.2105/ajph.86.5.642. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hurley S. F., Kaldor J. M., Carlin J. B., Gardiner S., Evans D. B., Chondros P., Hoy J., Spelman D., Spicer W. J., Wraight H. The usage and costs of health services for HIV infection in Australia. AIDS. 1995 Jul;9(7):777–785. doi: 10.1097/00002030-199507000-00016. [DOI] [PubMed] [Google Scholar]
  11. Iannelli M., Loro R., Milner F., Pugliese A., Rabbiolo G. An AIDS model with distributed incubation and variable infectiousness: applications to i.v. drug users in Latium, Italy. Eur J Epidemiol. 1992 Jul;8(4):585–593. doi: 10.1007/BF00146381. [DOI] [PubMed] [Google Scholar]
  12. Kaplan E. H. Economic analysis of needle exchange. AIDS. 1995 Oct;9(10):1113–1119. doi: 10.1097/00002030-199510000-00001. [DOI] [PubMed] [Google Scholar]
  13. Kaplan E. H., Heimer R. A circulation theory of needle exchange. AIDS. 1994 May;8(5):567–574. doi: 10.1097/00002030-199405000-00001. [DOI] [PubMed] [Google Scholar]
  14. Kaplan E. H., Heimer R. HIV incidence among New Haven needle exchange participants: updated estimates from syringe tracking and testing data. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Oct 1;10(2):175–176. doi: 10.1097/00042560-199510020-00010. [DOI] [PubMed] [Google Scholar]
  15. Kaplan E. H., Heimer R. HIV incidence among needle exchange participants: estimates from syringe tracking and testing data. J Acquir Immune Defic Syndr. 1994 Feb;7(2):182–189. [PubMed] [Google Scholar]
  16. Kaplan E. H. Needles that kill: modeling human immunodeficiency virus transmission via shared drug injection equipment in shooting galleries. Rev Infect Dis. 1989 Mar-Apr;11(2):289–298. doi: 10.1093/clinids/11.2.289. [DOI] [PubMed] [Google Scholar]
  17. Krahn M., Gafni A. Discounting in the economic evaluation of health care interventions. Med Care. 1993 May;31(5):403–418. doi: 10.1097/00005650-199305000-00003. [DOI] [PubMed] [Google Scholar]
  18. Käll K. I., Olin R. G. HIV status and changes in risk behaviour among intravenous drug users in Stockholm 1987-1988. AIDS. 1990 Feb;4(2):153–157. doi: 10.1097/00002030-199002000-00009. [DOI] [PubMed] [Google Scholar]
  19. Ljungberg B., Christensson B., Tunving K., Andersson B., Landvall B., Lundberg M., Zäll-Friberg A. C. HIV prevention among injecting drug users: three years of experience from a syringe exchange program in Sweden. J Acquir Immune Defic Syndr. 1991;4(9):890–895. [PubMed] [Google Scholar]
  20. Metzger D. S., Woody G. E., McLellan A. T., O'Brien C. P., Druley P., Navaline H., DePhilippis D., Stolley P., Abrutyn E. Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: an 18-month prospective follow-up. J Acquir Immune Defic Syndr. 1993 Sep;6(9):1049–1056. [PubMed] [Google Scholar]
  21. Moore R. D., Hidalgo J., Bareta J. C., Chaisson R. E. Zidovudine therapy and health resource utilization in AIDS. J Acquir Immune Defic Syndr. 1994 Apr;7(4):349–354. [PubMed] [Google Scholar]
  22. Nelson K. E., Vlahov D., Solomon L., Cohn S., Muñoz A. Temporal trends of incident human immunodeficiency virus infection in a cohort of injecting drug users in Baltimore, Md. Arch Intern Med. 1995 Jun 26;155(12):1305–1311. [PubMed] [Google Scholar]
  23. Rietmeijer C. A., Davidson A. J., Foster C. T., Cohn D. L. Cost of care for patients with human immunodeficiency virus infection. Patterns of utilization and charges in a public health care system. Arch Intern Med. 1993 Jan 25;153(2):219–225. [PubMed] [Google Scholar]
  24. Turner H. A., Catania J. A., Gagnon J. The prevalence of informal caregiving to persons with AIDS in the United States: caregiver characteristics and their implications. Soc Sci Med. 1994 Jun;38(11):1543–1552. doi: 10.1016/0277-9536(94)90116-3. [DOI] [PubMed] [Google Scholar]
  25. Watters J. K., Estilo M. J., Clark G. L., Lorvick J. Syringe and needle exchange as HIV/AIDS prevention for injection drug users. JAMA. 1994 Jan 12;271(2):115–120. [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES